MedTrace Logo

Microbiome Fructan Metabolism and Symptoms in Childhood IBS

NCT02842281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2021-01-22

No results posted yet for this study

Summary

This study evaluates whether the gut microbiome is involved in determining whether children with irritable bowel syndrome (IBS) develop worsening GI symptoms (e.g. pain) when given fructans (a sugar often found in wheat). Participants will both receive a diet with fructans and a diet without fructans.

Conditions

  • Irritable Bowel Syndrome (IBS)

Interventions

OTHER

Fructan

Short-chain oligosaccharide primarily composed of fructose polymers

OTHER

Maltodextrin

Polysaccharide produced from starch

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Bruno Chumpitazi, MD, MPH · Assistant Professor

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-03-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02842281 on ClinicalTrials.gov